137 related articles for article (PubMed ID: 4068904)
1. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
Watanabe H
Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904
[TBL] [Abstract][Full Text] [Related]
2. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
[TBL] [Abstract][Full Text] [Related]
3. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
Bacopoulos NG; Roth RH
Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
[TBL] [Abstract][Full Text] [Related]
4. Reduced apomorphine sensitivity of dopamine metabolism in rat striatum after repeated administration of methamphetamine.
Kashihara K; Sato M; Fukuda K; Fujiwara Y; Otsuki S
Neurosci Res; 1986 May; 3(4):351-5. PubMed ID: 3725224
[TBL] [Abstract][Full Text] [Related]
5. Effects of reserpine and antidepressants on dopamine and DOPAC (3,4-dihydroxyphenylacetic acid) concentrations in the striatum, olfactory tubercle and median eminence of rats.
Fekete MI; Szentendrei T; Herman JP; Kanyicska B
Eur J Pharmacol; 1980 Jun; 64(4):231-8. PubMed ID: 7389821
[TBL] [Abstract][Full Text] [Related]
6. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Kaneno S; Watanabe A; Takahashi R
Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
[TBL] [Abstract][Full Text] [Related]
7. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
Maidment NT; Marsden CA
Eur J Pharmacol; 1987 Apr; 136(2):141-9. PubMed ID: 3595718
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
Wheeler SC; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
[TBL] [Abstract][Full Text] [Related]
9. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
Estrella CR; Bregonzio C; Cabrera RJ
Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
[TBL] [Abstract][Full Text] [Related]
10. Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats.
Möller HG; Nowak K; Kuschinsky K
Psychopharmacology (Berl); 1987; 91(1):50-5. PubMed ID: 3029794
[TBL] [Abstract][Full Text] [Related]
11. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
Diggory GL; Buckett WR
Eur J Pharmacol; 1984 Oct; 105(3-4):257-63. PubMed ID: 6510470
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures.
Govoni S; Petkov VV; Montefusco O; Missale C; Battaini F; Spano PF; Trabucchi M
J Pharm Pharmacol; 1984 Jul; 36(7):458-60. PubMed ID: 6146691
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact?
Finlay JM; Jakubovic A; Fu DS; Fibiger HC
Eur J Pharmacol; 1987 May; 137(1):117-21. PubMed ID: 3609130
[TBL] [Abstract][Full Text] [Related]
14. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
Matthews RT; Champney TH; Frye GD
Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
[TBL] [Abstract][Full Text] [Related]
15. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
[TBL] [Abstract][Full Text] [Related]
16. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
Nomura Y; Oki K; Segawa T
J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
[TBL] [Abstract][Full Text] [Related]
17. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
[TBL] [Abstract][Full Text] [Related]
18. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
Coyle S; Napier TC; Breese GR
Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
[TBL] [Abstract][Full Text] [Related]
19. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
Conway P; Uretsky NJ
Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
[TBL] [Abstract][Full Text] [Related]
20. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
Yamada S; Yokoo H; Nishi S
Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
